A federal judge in Indiana has pared back a consumer lawsuit accusing animal health company Elanco Animal Health Inc. of monopolizing the market for certain flea and tick treatments, according to Reuters. The case, which centers on allegations that the company’s business practices led to inflated prices for its Advantix line of products, will continue under state antitrust laws despite the dismissal of federal claims.
Featured News
Starbucks Explored Chipotle Takeover in Potential Restaurant Megadeal
Oct 8, 2026 by
CPI
MMG Challenges EU Antitrust Case Against $500 Million Nickel Deal
Oct 8, 2026 by
CPI
Block, Parent of Cash App and Square, Faces FTC Probe Over Frozen Accounts
Oct 8, 2026 by
CPI
Michigan Sues Blue Cross Blue Shield Over Alleged Antitrust Violations
Oct 8, 2026 by
CPI
AkzoNobel, Axalta Near EU Approval for $25 Billion Merger
Oct 8, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – National Security
Sep 22, 2026 by
CPI
National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by
Rod Rosenstein & Timothy Finley
The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by
Eric Stocking & Paul Ney
National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by
Beatriz Marques
National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by
Roslyn Layton